While the use of HUVEC cells may have some limitations compared to normal endothelial cells, concerns over the targeting of CD73-directed NK cells to non-tumor tissues can be alleviated by administering these cells locally, such as intratumorally Dubinett et al., 2010; Lee et al., 2017. This evidence concerns the gene NT5E and neoplasm.